Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Allarity Therapeutics, Inc. - Common stock
(NQ:
ALLR
)
0.2168
-0.0098 (-4.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,921,312
Open
0.2224
Bid (Size)
0.2150 (5)
Ask (Size)
0.2199 (7)
Prev. Close
0.2266
Today's Range
0.2125 - 0.2254
52wk Range
0.1850 - 13.49
Shares Outstanding
198,742,643
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Allarity Granted Hearing Before Nasdaq Panel to Present Plan of Regaining Compliance
June 27, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
Allarity Therapeutics’ Dual PARP/Tankyrase Inhibitor, Stenoparib, Continues to Show Extended Clinical Benefit in Advanced Ovarian Cancer
June 25, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
Performance
YTD
-60.08%
-60.08%
1 Month
-64.45%
-64.45%
3 Month
-10.93%
-10.93%
6 Month
-60.08%
-60.08%
1 Year
-96.56%
-96.56%
More News
Read More
Why Allarity Therapeutics (ALLR) Stock Is Getting Hammered
June 24, 2024
Via
Benzinga
Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher
June 24, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
June 24, 2024
Via
InvestorPlace
Allarity Therapeutics Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
May 20, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
ALLR Stock Earnings: Allarity Therapeutics Reported Results for Q1 2024
May 15, 2024
Via
InvestorPlace
Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Balances
May 14, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 07, 2024
Via
Benzinga
Allarity Therapeutics Announces that All Series A Preferred and All Variable Priced Warrants have Converted to Common Stock
May 07, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 06, 2024
Via
Benzinga
Allarity Therapeutics Exceeds Nasdaq’s Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1
May 06, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
May 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
May 02, 2024
Via
Benzinga
Why Is Nano-Cap Allarity Therapeutics Stock Trading Up On Thursday?
May 02, 2024
Via
Benzinga
JPMorgan Just Raised Its Price Target on Carvana (CVNA) Stock
May 02, 2024
Via
InvestorPlace
Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts
May 02, 2024
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Why Is Allarity Therapeutics (ALLR) Stock Up 39% Today?
May 02, 2024
Via
InvestorPlace
Nasdaq Jumps Over 100 Points; Kellanova Posts Upbeat Results
May 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 02, 2024
Via
Benzinga
Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer
May 02, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement
April 29, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
April 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 18, 2024
Via
Benzinga
Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)
April 17, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.